BIOGEN INC. Quarterly Deferred Income Tax Assets, Net in USD from Q4 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.
Summary
Biogen Inc. quarterly Deferred Income Tax Assets, Net history and growth rate from Q4 2019 to Q2 2024.
  • Biogen Inc. Deferred Income Tax Assets, Net for the quarter ending June 30, 2024 was $915M, a 24.3% decline year-over-year.
Deferred Income Tax Assets, Net, Quarterly (USD)
Deferred Income Tax Assets, Net, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $915M -$293M -24.3% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $898M -$314M -25.9% Mar 31, 2024 10-Q 2024-04-24
Q4 2023 $929M -$298M -24.3% Dec 31, 2023 10-Q 2024-08-01
Q3 2023 $1.07B -$105M -8.91% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $1.21B -$27.3M -2.21% Jun 30, 2023 10-Q 2023-07-25
Q1 2023 $1.21B -$77M -5.98% Mar 31, 2023 10-Q 2023-04-25
Q4 2022 $1.23B -$189M -13.3% Dec 31, 2022 10-K 2024-02-14
Q3 2022 $1.17B -$636M -35.1% Sep 30, 2022 10-Q 2022-10-25
Q2 2022 $1.24B -$614M -33.2% Jun 30, 2022 10-Q 2022-07-20
Q1 2022 $1.29B +$2.5M +0.19% Mar 31, 2022 10-Q 2022-05-03
Q4 2021 $1.42B +$45.6M +3.33% Dec 31, 2021 10-K 2023-02-15
Q3 2021 $1.81B +$438M +31.9% Sep 30, 2021 10-Q 2021-10-20
Q2 2021 $1.85B +$140M +8.17% Jun 30, 2021 10-Q 2021-07-22
Q1 2021 $1.29B -$1.82B -58.6% Mar 31, 2021 10-Q 2021-04-22
Q4 2020 $1.37B -$1.86B -57.6% Dec 31, 2020 10-K 2022-02-03
Q3 2020 $1.37B Sep 30, 2020 10-Q 2020-10-21
Q2 2020 $1.71B Jun 30, 2020 10-Q 2020-07-22
Q1 2020 $3.11B Mar 31, 2020 10-Q 2020-04-23
Q4 2019 $3.23B Dec 31, 2019 10-K 2021-02-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.